The Application of Glycolipid-Type Microbial Biosurfactants as Active Pharmaceutical Ingredients for the Treatment and Prevention of Cancer

Pharmaceutical scientists have researched the potential of secondary metabolites biosynthesized by microorganisms as active pharmaceutical ingredients (APIs) for the treatment of cancer. Ideally, these APIs should possess anticancer bioactivity that specifically targets tumor cells while having litt...

Full description

Bibliographic Details
Published in:Pharmaceuticals
Main Authors: Aileen M. B. McMahon, Matthew S. Twigg, Roger Marchant, Ibrahim M. Banat
Format: Article
Language:English
Published: MDPI AG 2025-05-01
Subjects:
anticancer
microbial
biosurfactant
glycolipid
rhamnolipids
sophorolipids
Online Access:https://www.mdpi.com/1424-8247/18/5/676

Internet

https://www.mdpi.com/1424-8247/18/5/676

Similar Items